Work

Evaluation of clinical endpoints as surrogates for overall survival in patients treated with immunotherapies.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.e14557

Authors: Howard Kaufman, Lawrence Howard Schwartz, William N. William, Mario Sznol, Michael del Aguila, Craig Whittington, Kyle Fahrbach, Yingxin Xu, Eric Masson, Sara Dempster, Andrea Leninka Vergara-Silva

Institutions: Rutgers Cancer Institute, Columbia University Irving Medical Center, The University of Texas MD Anderson Cancer Center, Yale Cancer Center, AstraZeneca (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890257640

Cites:

Cited by: 11

Related to: 10